“There is now no question that KDI can be therapeutic and help prevent and even reverse some of the outcomes of these devastating neurological disorders, said Dr. Liesi, a former visiting scientist at the National Institutes of Health (NIH).
In the study, an injection of KDI protected the brain’s of mice from the brain cell death that occurs with Parkinson’s disease. These results could lead to a biological treatment that would effectively prevent brain cell damage from Parkinson’s disease.
“This is a groundbreaking approach to treating Parkinson’s disease, said George Martin, Ph.D., former scientific director for the National Institute on Aging. “Rather than focusing on treating the symptoms of Parkinson’s after they have already affected people’s lives, these results show that symptoms may be treatable from the start.
KDI is also the focus of studies for the treatment of ALS or Lou Gehrig’s disease and the effects of stroke.
